Objective: Clinical evidence suggests that the risk stratification of portal hypertension (PH) plays a vital role in disease progression and patient outcomes. However, the gold standard for stratifying PH [portal vein pressure (PVP) measurement] is invasive and therefore not suitable for routine clinical practice. This study is aimed to stratify PH and predict patient outcomes using liver or spleen texture features based on computed tomography (CT) images non-invasively.Methods: A total of 114 patients with PH were included in this retrospective study and divided into high-risk PH (PVP ≥ 20 mm Hg, n = 57) or low-risk PH (PVP < 20 mm Hg, n = 57), a progression-free survival (PFS) group (n = 14), or a non-PFS group (n = 51) based on patients with rebleeding or death after the transjugular intrahepatic portosystemic shunt (TIPS) procedure. All patients underwent contrast-enhanced CT, and the laboratory data were recorded. Texture features of the liver or spleen were obtained by a manual drawing of the region of interest (ROI) and were performed in the portal venous phase. Logistic regression analysis was applied to select the significant features related to high-risk PH, and PFS-related features were determined by the Cox proportional hazards model and Kaplan-Meier analysis. Receiver operating characteristic (ROC) curves were used to test the diagnostic capacity of each feature.Results: Five texture features (one first-order feature from the liver and four wavelet features from the spleen) and the international normalized ratio (INR) were identified as statistically significant for stratifying PH (p < 0.05). The best performance was achieved by the spleen-derived feature of wavelet.LLH_ngtdm_Busyness, with an AUC of 0.72. The only log.sigma.3.0.mm.3D_firstorder_RobustMeanAbsoluteDeviation feature from the liver was associated with PFS with a C-index of 0.72 (95% CI 0.566–0.885), which could stratify patients with PH into high- or low-risk groups. The 1-, 2-, and 3-year survival probabilities were 66.7, 50, and 33.3% for the high-risk group and 93.2, 91.5, and 84.4% for the low-risk group, respectively (p < 0.05).Conclusion: CT-based texture features from the liver or spleen may have the potential to stratify PH and predict patient survival.
Background: Although patients with stable angina pectoris (SAP) are generally considered to be at lower risk than those with acute coronary syndromes (ACS), their risk of major adverse cardiovascular events (MACEs) remains substantial. Lesion-specific pericoronary adipose tissue attenuation (PCATa-lesion) reflects local coronary inflammation, and the triglyceride-glucose body mass index (TyG-BMI) is a robust surrogate of insulin resistance (IR) and metabolic dysfunction; however, their combined prognostic value remains unclear. This study aimed to evaluate whether incorporating TyG-BMI and PCATa-lesion into conventional clinical and coronary computed tomography angiography (CCTA) models improves MACEs prediction and risk stratification in SAP patients. Methods: In this retrospective study, patients with SAP who underwent CCTA from January 2017 to December 2020 were included. Clinical and imaging data were collected, including PCATa-lesion, TyG-BMI, plaque characteristics, and coronary artery calcium score (CACS). Statistical analyses included Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), time-dependent receiver operating characteristic curve, Kaplan-Meier analysis and decision curve analysis (DCA). Results: A total of 212 patients were enrolled, with 43 MACEs occurring over a median follow-up of 36 months. Multivariable Cox regression analysis identified age (HR =1.052, 95% CI: 0.999–1.108; P=0.049), degree of stenosis (DS) (HR =1.079, 95% CI: 1.047–1.112; P=0.031), TyG-BMI (HR =2.198, 95% CI: 1.091–4.426; P=0.027) and PCATa-lesion (HR =1.117, 95% CI: 1.067–1.169, P<0.001) as independent predictors of MACEs. Kaplan-Meier curve demonstrated that patients in the highest tertile of PCATa-lesion and those with elevated TyG-BMI had a significantly increased risk of MACEs (P<0.001). Higher PCATa-lesion values were also significantly associated with increased incidence of high-risk plaques (HRP) (P=0.014). Subgroup analysis revealed a significant difference in PCATa-lesion between SAP patients with and without comorbid diabetes mellitus (DM) (P=0.016); importantly, elevated PCATa-lesion levels were associated with a substantially higher risk of adverse events in DM patients compared to non-DM individuals. Furthermore, the integrated model incorporating PCATa-lesion and TyG-BMI demonstrated superior goodness-of-fit, discriminatory ability, and net clinical benefit across a range of risk thresholds compared to the conventional model (age and DS only). Conclusions: PCATa-lesion is an independent prognostic factor for MACEs in patients with SAP. The combination of PCATa-lesion and TyG-BMI provides incremental predictive value for assessing MACEs risk in SAP patients.
To compare the assessment agreement and diagnostic performance of CT and MRI using the Node Reporting and Data System (Node-RADS) for preoperative regional lymph node metastasis (LNM) in rectal cancer. This retrospective study included 97 rectal adenocarcinoma patients who underwent preoperative contrast-enhanced CT and MRI. A total of 148 lymph nodes (LNs) were evaluated. Postoperative histopathology served as the reference standard. CT-based and MRI-based Node-RADS scores, as well as the ESGAR category, were assessed. Diagnostic performance was evaluated by receiver operating characteristic (ROC) curve analysis, including area under the curve (AUC), sensitivity, and specificity. Inter- and intra-observer agreement for Node-RADS was evaluated using weighted kappa statistics. A subgroup analysis was further conducted on 27 image-pathology matched LNs. Node-RADS scores showed a strong positive correlation with pathological N stage (MRI: r = 0.724; CT: r = 0.654; both p < 0.01). MRI-based Node-RADS achieved the highest diagnostic performance , which was significantly higher than CT-based Node-RADS and the ESGAR . Inter-reader agreement for Node-RADS was good to excellent for both modalities, and was higher for MRI () than CT (). For small LNs (<5 mm in short axis diameter), MRI-based Node-RADS demonstrated a higher AUC than CT-based Node-RADS (0.895 vs. 0.760). In the imaging–pathology matched subgroup, MRI-based Node-RADS also outperformed CT-based Node-RADS . Node-RADS provides a standardized tool for preoperative regional lymph node assessment in rectal cancer, showing better diagnostic performance than ESGAR criteria. MRI demonstrates higher diagnostic performance and inter-observer agreement than CT, supporting MRI as the preferred modality.